Title : Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.

Pub. Date : 2017 Feb 28

PMID : 28241849






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Results of western blot confirm that metformin and ATO cooperated to inhibit mTORC1, activate AMP-activated protein kinase (AMPK), and upregulate ERK3. Metformin CREB regulated transcription coactivator 1 Mus musculus
2 Inactivation of p38 MAPK by SB203580 or specific short interfering RNA (siRNA) promoted the inactivation of mTORC1 in ICC cells treated with metformin and ATO. Metformin CREB regulated transcription coactivator 1 Mus musculus
3 CONCLUSIONS: Metformin sensitizes arsenic trioxide to suppress intrahepatic cholangiocarcinoma via the regulation of AMPK/p38 MAPK-ERK3/mTORC1 pathways. Metformin CREB regulated transcription coactivator 1 Mus musculus